FINEP Economic Subsidy (Subvenção Econômica; Mais Inovação Brasil)

FINEP Mais Inovação Brasil — Health Industrial Complex (Saúde / Complexo Industrial da Saúde)

Funds Brazilian healthcare innovation in pharmaceuticals and life-science manufacturing partnerships.

FINEP Mais Inovação Brasil — Saúde / Complexo Industrial da Saúde is a thematic edital under Mais Inovação Brasil Rodada 2, allocating R$ 300 million to company-led innovation in health products, pharmaceuticals, medical devices, and health technology. The programme's strategic objective is to build Brazil's domestic health industrial complex (Complexo Econômico-Industrial da Saúde, CEIS), reducing import dependence in medicines, inputs, and medical equipment. Funding is non-reimbursable subvenção econômica via FNDCT, administered by FINEP under MCTI.

Only Brazilian-registered for-profit companies may serve as principal executors. ICT co-executors may participate but are not mandatory. A financial counterpart contribution (contrapartida) is required at a proportion defined in the edital. The R$ 300 million pool is distributed competitively; per-project award size is not specified in the available sources. Projects must demonstrate genuine technological innovation with a pathway to reducing the national health sector's dependence on foreign-sourced products. All submissions must be in Portuguese via the FINEP platform.

The submission deadline is 31 August 2026. Applications are submitted through cadastro.finep.gov.br. FINEP's evaluation criteria for this edital emphasise technical innovation, industrial scalability, strategic alignment with CEIS policy priorities, and the applicant's capacity to manufacture and distribute in Brazil. Medtech companies, pharmaceutical developers, and diagnostic technology firms are among the primary target applicants. The full edital on the FINEP portal specifies contrapartida rates, eligible cost categories, minimum and maximum project awards, and the scoring rubric.